Skip to main content

Table 3 Fatty acid distribution of cellular lipids treated with different milk lipids at 8 h

From: Influence of in vitro supplementation with lipids from conventional and Alpine milk on fatty acid distribution and cell growth of HT-29 cells

 

Control

 

MLcon

MLalp

 

0.25% EtOH

 

100 μM

 

200 μM

 

100 μM

 

200 μM

 

FAME [%]

Mean

 

SD

 

Mean

 

SD

 

Mean

 

SD

 

Mean

 

SD

 

Mean

 

SD

 

C14:0

1.58

±

0.39

d

6.38

±

0.87

bc

7.96

±

0.94

a

5.38

±

0.57

c

6.81

±

0.51

ab

C14:1 c 9

0.10

±

0.04

d

0.24

±

0.05

bc

0.33

±

0.05

a

0.22

±

0.05

c

0.30

±

0.03

ab

C15:0

0.25

±

0.03

d

1.02

±

0.09

bc

1.18

±

0.08

a

1.08

±

0.09

c

1.28

±

0.07

ab

C16:0

20.92

±

0.95

d

34.53

±

1.89

b

36.96

±

1.35

a

26.52

±

1.14

c

26.77

±

0.99

c

C16:1 c 9

12.75

±

0.74

a

8.11

±

0.80

b

6.64

±

0.52

c

7.11

±

0.51

bc

5.58

±

0.36

d

C16:2 t 7,c 9

-

 

-

 

-

 

0.03

±

0.01

b

0.05

±

0.01

a

C17:0

0.44

±

0.03

c

0.64

±

0.04

b

0.63

±

0.02

b

0.69

±

0.04

a

0.67

±

0.02

ab

C18:0

13.02

±

0.47

a

10.23

±

0.29

b

9.34

±

0.63

c

10.13

±

0.37

b

8.66

±

0.27

c

C18:1 c 9

34.32

±

0.82

a

25.93

±

1.71

c

25.02

±

1.66

c

29.23

±

1.32

b

29.05

±

1.34

b

C18:1 c 11

3.25

±

0.18

a

1.85

±

0.24

b

1.47

±

0.08

c

1.90

±

0.12

b

1.56

±

0.07

c

C18:1 c 12-15

-

 

0.31

±

0.10

b

0.39

±

0.09

ab

0.42

±

0.13

ab

0.48

±

0.11

a

C18:1 t 4-8

-

 

0.03

±

0.01

bc

0.03

±

0.01

bc

0.08

±

0.06

ab

0.11

±

0.05

a

C18:1 t 9

-

 

0.10

±

0.03

b

0.10

±

0.04

b

0.16

±

0.04

ab

0.19

±

0.07

a

C18:1 t 10

-

 

0.14

±

0.04

b

0.18

±

0.03

b

0.19

±

0.04

b

0.25

±

0.05

a

C18:1 t 11 (VA)

-

 

0.27

±

0.03

c

0.34

±

0.03

c

2.50

±

0.20

b

3.32

±

0.16

a

C18:1 t 12-16

-

 

0.42

±

0.14

c

0.54

±

0.18

bc

0.75

±

0.19

ab

0.92

±

0.20

a

C18:2 n-6

2.65

±

0.13

a

2.08

±

0.05

cd

2.04

±

0.17

d

2.28

±

0.07

b

2.25

±

0.11

bc

C18:2 n-6 (t,t)

-

 

0.21

±

0.06

d

0.29

±

0.03

c

0.43

±

0.04

b

0.54

±

0.03

a

C18:2 c 9,t 11

0.09

±

0.01

e

0.32

±

0.01

d

0.37

±

0.03

c

2.47

±

0.07

b

3.18

±

0.14

a

C18:2 t 11,c 13

-

 

-

 

-

 

0.18

±

0.02

b

0.26

±

0.02

a

C18:2 t 9,t 11

-

 

0.03

±

0.01

cd

0.04

±

0.01

c

0.18

±

0.02

b

0.24

±

0.03

a

C18:3 n-3

0.22

±

0.03

d

0.33

±

0.02

c

0.42

±

0.05

c

0.96

±

0.02

b

1.31

±

0.09

a

C20:0

0.38

±

0.03

a

0.30

±

0.02

b

0.24

±

0.03

c

0.28

±

0.02

b

0.20

±

0.02

c

C20:1 c 9

0.33

±

0.07

a

0.17

±

0.04

bc

0.15

±

0.02

d

0.23

±

0.04

b

0.18

±

0.02

bc

C20:3 n-6

1.19

±

0.14

a

0.63

±

0.05

b

0.49

±

0.04

cd

0.58

±

0.06

bc

0.42

±

0.05

d

C20:4 n-6

2.38

±

0.25

a

1.20

±

0.09

b

0.86

±

0.05

c

1.13

±

0.13

b

0.77

±

0.09

c

C20:5 n-3

0.70

±

0.05

a

0.35

±

0.04

bc

0.27

±

0.02

d

0.39

±

0.03

b

0.31

±

0.03

cd

C22:5 n-3

1.34

±

0.15

a

0.70

±

0.11

b

0.53

±

0.06

c

0.69

±

0.08

bc

0.54

±

0.07

bc

C22:6 n-3

1.76

±

0.16

a

0.82

±

0.11

b

0.58

±

0.05

c

0.78

±

0.10

b

0.53

±

0.07

c

∑ SFA

38.65

±

0.88

a

55.47

±

2.59

b

58.67

±

1.83

a

46.78

±

1.59

c

47.29

±

1.66

c

∑ MUFA

50.84

±

0.34

b

37.69

±

2.28

c

35.30

±

1.49

c

42.91

±

1.34

b

42.07

±

1.22

b

∑ PUFA incl. CLA

10.51

±

0.86

a

6.84

±

0.47

b

6.03

±

0.44

b

10.31

±

0.44

a

10.64

±

0.56

a

∑ PUFA n-3

4.14

±

0.36

a

2.31

±

0.28

c

1.88

±

0.16

c

2.95

±

0.21

b

2.82

±

0.22

b

∑ PUFA n-6

6.28

±

0.51

a

3.98

±

0.18

bc

3.46

±

0.25

d

4.07

±

0.25

b

3.54

±

0.23

cd

PUFA/SFA

0.27

±

0.03

a

0.12

±

0.01

c

0.10

±

0.01

c

0.22

±

0.02

b

0.23

±

0.02

b

n-6/n-3

1.52

±

0.06

b

1.74

±

0.17

a

1.85

±

0.07

a

1.38

±

0.03

bc

1.26

±

0.02

c

∑ SFA + t FA

38.65

±

0.88

d

56.71

±

2.73

b

60.23

±

2.06

a

50.97

±

2.04

c

52.73

±

1.91

c

∑ C18:1 (t)

-

 

0.96

±

0.18

c

1.18

±

0.26

c

3.68

±

0.46

b

4.79

±

0.38

a

C18:1 t 9,t 11

-

 

0.37

±

0.10

a

0.28

±

0.09

a

0.06

±

0.01

b

0.06

±

0.02

b

∑ CLA

0.09

±

0.01

d

0.35

±

0.02

c

0.41

±

0.04

c

2.83

±

0.07

b

3.68

±

0.15

a

VA + C18:2 c 9,t 11

0.09

±

0.01

d

0.59

±

0.04

c

0.71

±

0.03

c

4.97

±

0.25

b

6.50

±

0.30

a

∑ BCFA

0.44

±

0.12

d

1.59

±

0.15

c

1.83

±

0.13

b

1.97

±

0.16

b

2.38

±

0.14

a

  1. FA distribution of HT-29 cells after incubation with milk lipids (ML conventional and ML Alpine) given as FFA-mixtures in ethanol. Means (n = 6) of FAME [%] significantly differ without the same letter (a, b, c, d), two-way ANOVA Tukey post hoc test P < 0.05.